Found 276 matching trials
A Single-arm, Open-label, Prospective Clinical Study of Surufatinib Combined With Immunotherapy and Chemotherapy for Unresectable or Metastatic Biliary Tract Cancer. PHASE2 This is a single-arm, open-label, prospective clinical study aimed at obser...
Show More Location
Multiple Locations
Learn More & Join Trial
Neoadjuvant vs Adjuvant in Locally Advanced Recurrent NPC PHASE3 A multicenter randomized controlled study of surgery combined with neoadjuv...
Show More Location
Eye& ENT Hospital, Fudan University
Learn More & Join Trial
A Single-center Phase II Study to Investigate the Immune Maintenance Therapy Pattern in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Who Have Achieved MPR After Neoadjuvant Immunotherapy Combined With Chemotherapy PHASE2 Head and neck cancer is the malignant tumor with the highest morbidity and ...
Show More Location
Tianjin Medical University Cancer Institute and Hospital
Learn More & Join Trial
PD-1 Antibody Combined With Chemoradiotherapy in Recurrent Nasopharyngeal Carcinoma Patients PHASE3 This is a multicenter, randomized controlled, phase III clinical trial. The...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Neoadjuvant Chemotherapy Plus Toripalimab in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma PHASE2 Neoadjuvant chemotherapy plus toripalimab in patients with locoregionally a...
Show More Status
Active Not Recruiting
Location
Zhejiang Cancer Hospital
Learn More & Join Trial
HAIC Combined With Lenvatinib and PD-1 Inhibitor in Infiltrative Hepatocellular Carcinoma N/A Hepatic arterial infusion chemotherapy (HAIC) plus lenvatinib and programme...
Show More Location
Chinese PLA General hospital
Learn More & Join Trial
Newly Emerging Immunotherapy for Pancreatic Cancer Treatment PHASE1 This is a Phase Ib/II platform clinical study to evaluate the initial effic...
Show More Location
Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University
Learn More & Join Trial
Randomized Trial of Glutathione With Anti-PD-1 and Chemotherapy in Advanced NSCLC PHASE1 Chemotherapeutic agents exert significant immunomodulatory effects by influ...
Show More Location
the First Affiliated Hospital of Zhengzhou University
Learn More & Join Trial
Toripalimab Combined With Different Platinum-Based Induction Chemotherapy Regimens for Locally Advanced Nasopharyngeal Carcinoma PHASE2 This phase II randomized trial compares the efficacy and safety of Toripali...
Show More Location
Dongguan People's Hospital
Learn More & Join Trial
Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma N/A This study is conducted to evaluate the efficacy, prognosis, adverse effect...
Show More Location
The Second Affiliated Hospital of Fujian Medical University
Learn More & Join Trial